Kolterman, O
Borghi C, Cicero AF
doi: 10.1111/dom.16548 171 KnakkerBInkellerJKovcsPLendvaiBHerndiI
Many products are research-grade and may lack consistent quality standards
majority of component data Mice Used for genetic models, IBD research (C57BL/6, BALB/c, MC1R knockout strains), mechanism studies Rabbits Employed in orthopedic, cardiovascular, and fever studies Cell culture Fibroblasts, endothelial cells, keratinocytes, intestinal epithelial cells (Caco2-BBE, HT29), T cells (Jurkat), bronchial epithelial cells, various tissue-specific lines Dogs Limited studies primarily for BPC-157 pharmacokinetics and cardiovascular research Ex vivo systems Human skin explants for transdermal studies Research Limitations & Regulatory Status Critical Gaps in Current Evidence Despite extensive research on individual components, KLOW Blend faces substantial translational barriers that limit research utility and prevent any clinical application

In addition, in order for these drugs to become a public health tool for cancer treatment or prevention, more information would be necessary such as what cancers are most affected by GLP-1s, how long patients need to remain on therapy for the desired protection and whether benefits differ between different GLP-1 medications